Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2016

16.06.2016 | Letter to the Editor

Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India

verfasst von: Ravindra Pramod Deshpande, Deepak Babu, Manas Panigrahi, Y. B. V. K. Chandra Sekhar, Phanithi Prakash Babu

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Excerpt

Brain tumor is a collection of abnormally grown cells in brain, contributing total 256,213 new cases reported globally in 2012. In USA, 68,470 brain tumor cases were reported in the year 2015 [1]. Overall, males are reported to be more prone to brain tumors than females with 7.7 males and 5.4 females per 100,000 persons [2]. World Health Organization (WHO) has classified brain tumors into diverse groups based on histopathological features and cellular origin [3]. Among all groups, gliomas appear to be the most common primary brain tumors [1, 3]. Despite of aggressive chemo and radio therapy, the median survival age for malignant gliomas is very low [4]. …
Literatur
3.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109CrossRefPubMedPubMedCentral Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Van den Bent MJ, Bromberg JE (2015) Neuro-oncology: the many challenges of treating elderly glioblastoma patients. Nat Rev Neurol 11(7):374–375CrossRefPubMed Van den Bent MJ, Bromberg JE (2015) Neuro-oncology: the many challenges of treating elderly glioblastoma patients. Nat Rev Neurol 11(7):374–375CrossRefPubMed
5.
Zurück zum Zitat Davis F, McCarthy BJ, Berger MS (1999) Centralized databases available for describing primary brain tumor incidence, survival, and treatment: central brain tumor registry of the United States; surveillance, epidemiology, and end results; and National Cancer Data Base. Neuro-oncology 1(3):205–211PubMedPubMedCentral Davis F, McCarthy BJ, Berger MS (1999) Centralized databases available for describing primary brain tumor incidence, survival, and treatment: central brain tumor registry of the United States; surveillance, epidemiology, and end results; and National Cancer Data Base. Neuro-oncology 1(3):205–211PubMedPubMedCentral
7.
Zurück zum Zitat Jalali R, Datta D (2008) Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India. J Neuro-oncol 87:111–114CrossRef Jalali R, Datta D (2008) Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India. J Neuro-oncol 87:111–114CrossRef
8.
Zurück zum Zitat Babu R, Sharma R, Bagley JH, Hatef J, Friedman AH, Adamson C (2013) Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 119(1):121–130CrossRefPubMed Babu R, Sharma R, Bagley JH, Hatef J, Friedman AH, Adamson C (2013) Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 119(1):121–130CrossRefPubMed
9.
Zurück zum Zitat Kivelev J, Niemelä M, Blomstedt G, Roivainen R, Lehecka M, Hernesniemi J (2011) Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien) 153(2):261–270CrossRef Kivelev J, Niemelä M, Blomstedt G, Roivainen R, Lehecka M, Hernesniemi J (2011) Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien) 153(2):261–270CrossRef
10.
Zurück zum Zitat Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293(5):557–564CrossRefPubMed Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293(5):557–564CrossRefPubMed
11.
Zurück zum Zitat Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Path 21:1455–1465CrossRefPubMed Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Path 21:1455–1465CrossRefPubMed
12.
Zurück zum Zitat Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL (2007) Epidemiology of brain tumors. Neurol Clin 25(4):867–890 (vii)CrossRefPubMed Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL (2007) Epidemiology of brain tumors. Neurol Clin 25(4):867–890 (vii)CrossRefPubMed
13.
Zurück zum Zitat Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62(12):3347–3350PubMed Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62(12):3347–3350PubMed
14.
Zurück zum Zitat Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-oncology 10(1):10–18CrossRefPubMedPubMedCentral Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-oncology 10(1):10–18CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Lehrer S, Labombardi V, Green S, Pessin-Minsley MS, Germano IM, Rosenzweig KE (2011) No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res 31(3):959–960PubMed Lehrer S, Labombardi V, Green S, Pessin-Minsley MS, Germano IM, Rosenzweig KE (2011) No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res 31(3):959–960PubMed
16.
Zurück zum Zitat Wick W, Platten M (2014) CMV infection and glioma, a highly controversial concept struggling in the clinical arena. Neuro-oncology 16(3):332–333CrossRefPubMedPubMedCentral Wick W, Platten M (2014) CMV infection and glioma, a highly controversial concept struggling in the clinical arena. Neuro-oncology 16(3):332–333CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Lehrer S, Green S, Ramanathan L, Rosenzweig K, Labombardi V (2012) No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. Anticancer Res 32(3):1113–1115PubMed Lehrer S, Green S, Ramanathan L, Rosenzweig K, Labombardi V (2012) No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. Anticancer Res 32(3):1113–1115PubMed
18.
Zurück zum Zitat Lehrer S (2012) Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor. Med Hypotheses 78(5):657–658CrossRefPubMed Lehrer S (2012) Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor. Med Hypotheses 78(5):657–658CrossRefPubMed
Metadaten
Titel
Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India
verfasst von
Ravindra Pramod Deshpande
Deepak Babu
Manas Panigrahi
Y. B. V. K. Chandra Sekhar
Phanithi Prakash Babu
Publikationsdatum
16.06.2016
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2016
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-016-2183-0

Weitere Artikel der Ausgabe 2/2016

Journal of Neuro-Oncology 2/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.